Tag:#Kai-Friedrich Niermann

German Government Should Focus On ‘Detail Not Speed’ As It Pressures Ministers To Accelerate Recreational Cannabis Roll Out

FEARS that German health ministers may be dragging their feet on rolling out cannabis legislation were definitively quashed earlier this month, as the Government...

German Courts Continue To Prosecute Hundreds Of Cannabis Businesses Despite Looming Legalisation

HUNDREDS of companies are still being hounded through the German courts for alleged breaches of the country’s strict cannabis laws - despite the country...

Germany Needs Workable Adult-Use Legislation Capable Of Drying-Up The Illicit Market.

Leading German Cannabis Lawyer Kai-Friedrich Niermann reflects on 2021 and looks ahead to the challenges and opportunities that lie ahead in 2022 BC: What are...

What Must Be Done To Enact Germany’s New Cannabis Law And What Will Its Adult-Use Market Look Like?

With Germany’s Government-in-waiting set to deliver adult-use cannabis, BusinessCann explores the delivery challenges and how the legislation may be shaped. BACK in 2015 the German...

The Policy Pathway For A Post-Election German Recreational Cannabis Market Outlined In A New Report

By German Cannabis Lawyer Kai-Friedrich Niermann and Burkhard Blienert, Political Advisor, former German MP and former drug policy spokesman of the SPD Bundestag’s group. LATER...

Germany’s Ban On CBD Flowers To Be Challenged In Ground-Breaking Court Case

AFTER failing to persuade the Government to permit the sale of CBD flowers German company Hanf Farm is turning to the courts. Within the next...

Is Germany Set To Become Europe’s First Recreational Cannabis Market?

A GREEN surge in Germany is opening up the possibility it could be the first European country to fully embrace adult-use cannabis. For large chunks...

Latest news

Germany Seeing Sense, High Tide Strikes Deal With Major German Player, European Expansion For Bedrocan, Danish Buy-Out, Greek First, £2m UK Hemp Boost

THE German Government’s refreshingly honest approach to drugs and addiction is being demonstrated with a focus on the harms...
- Advertisement -spot_imgspot_img

European Cannabis Stocks Review: Akanda Announces ‘First Significant Revenue Above Initial Projections’, Jazz Pharma Reimbursement Recommendation & Kanabo Climbs

Akanda  Akanda has enjoyed a sharp recovery in its share price this week, seeing its value return to levels not...

15% Of European Consumers Have Tried CBD, But Industry Held Back By ‘High Turnover Rate’ Of Users

THE European CBD market is set to see a ‘massive influx’ of previous and new consumers to the market...

Must read